(The hill) – The Food and Drug Administration (FDA) has released the first-ever smartphone app to help deliver mobile insulin to diabetics with iPhones and Android.
Tandem Diabetes Care has announced that the FDA has approved the delivery of insulin via the t: connect mobile app. news release on Thursday. This step is a major step towards improving the immediate care and use of technologies that will help smooth out the insulin delivery process. An estimated 37 million Americans have diabetessays Tandem.
T: connect allows people who use the company’s t: slim X2 insulin pump to inject insulin to “program and cancel insulin bolus requests using their compatible smartphone.”
John Sheridan, president and CEO of Tandem, said the FDA’s approval “confirms our commitment to innovation and diabetes by providing one of the most sought-after feature enhancements.”
“With the improvements in diabetes management provided by Tandem Control-IQ technology, the most common cause of human-pump interaction is now the most common cause of human-pump interaction, and the ability to do so with a smartphone app offers a convenient and discreet solution.” Sheridan said in a statement.
The app, compatible with both iPhone and Android, is paired with the t: slim X2 insulin pump and delivers information to the smartphone, including glucose trends, pump status changes and insulin therapy data.
The news comes amid a wider struggle to lower insulin prices in the US, as the drug is one of the most expensive in the country.
Centers for Disease Control and Prevention say that in 2020 One in 10 Americans has diabetes, and 88 million adults have had diabetes.
At the same time, the average annual cost of insulin per capita in 2018 approached $ 6,000, and the average annual price of insulin rose by 11 percent from 2001 to 2018. Report of the American Forum of Action for 2020.
The U.S. Action Forum said diabetes was worth $ 327 billion in 2017, “becoming the most expensive chronic disease in the country.”
President Biden included a a measure in the Build Back Better Act to limit the price of insulin to $ 35 for those who have private health care, personal insurance or Medicare, but Congress has stopped the law.
Tandem said its app doesn’t come at no extra cost to customers, and it will release an update in the spring with a limited launch team.